Serum adiponectin in relation to endometrial cancer and endometrial hyperplasia with atypia in obese women

European Journal of Gynaecological Oncology

Volumn 29, Issue 6, 2008, Pages 594-597

  Rzepka Gorska I ^a,b   Bedner, R ^a   Cymbaluk Ploska A ^a   Chudecka Glaz A ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b NONE   (Poland)

Author keywords

Adiponectine; Endometrial cancer; Endometrial hyperplasia; Obesity

Indexed keywords

ADIPONECTIN;

ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN BLOOD LEVEL;

ADIPONECTIN; CASE-CONTROL STUDIES; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; OBESITY;

EID: 56749116073     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Fruhbeck G., Gomez-Ambrozi J., Muruzaba F.J., Burrel M.A.: "The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation". Am. J. Physiol. Endocrinol. Metabol., 2001, 280, E827.
2. Gannage-Yared M.H., Khalife S., Semaan M., Fares F., Jambart S., Halaby G.: "Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men". Eur. J. Endocrinol., 2006, 155, 167.
3. Tataranni P.A., Ortega E.: "A burning question: does an adipokine-induced activation of the immune system mediate the effect of the overnutrition on type 2 diabetes"? Diabetes, 2005, 54, 917.
4. Kelesidis I., Kelesidis I., Mantzoros C.S.: "Adiponectin and cancer: a systematic review". Br. J. Cancer, 2006, 94, 1221.
5. Lara-Castro C., Fu Y., Chung B.H., Garvey W.T.: "Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease". Curr. Op. Lipidol., 2007, 18, 263.
6. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E.: "Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia". J. Clin. Endocrinol. Metabol., 2001, 86, 1930.
7. Cong L., Gasser J., Zhao J., Yang B., Li F., Zhao A.Z.: "Human adiponectine inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL 952". Endocr. Relat. Cancer, 2007, 14, 713.
8. Vona-Davis L., Rose D.P.: "Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression". Endocr Relat. Cancer, 2007, 14, 189.
9. Chow W.S., Cheung B.M., Tso A.W., Xu A., Wat N.M., Fong C.H. et al.: "Hypoadiponectinemia as a predictor for the development of hypertension. A 5-year prospective study". Hypertension, 2007, 49, 1455.
10. Brooks N.L., Moore K.S., Clark R.D., Perfetti M.T., Trent C.M., Combs T.P: "Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?". Diabet. Obstet. Metabol., 2007, 9, 246.
11. Ouchi N., Shibata R., Walsh K.: "Targeting adiponectin for cardioprotection". Exp. Opin. Ther. Targets, 2006, 10, 573.
12. Trujillo M.E., Scherer P.E.: "Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome". J. Int. Med., 2005, 257, 167.
13. Modan-Moses D., Stein D., Pariente C., Yaroslavsky A., Ram A., Faigin M. et al.: "Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients". J. Clin. Endocrinol. Metabol., 2007, 92, 1843.
14. Nagamani M., Stuart C.A.: "Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture". Am. J. Obstet. Gynecol., 1998, 179, 6.
15. Korner A., Kratzsch J., Gausche R., Schaab M., Erbs S., Kiess W.: "New predictors of the metabolic syndrome in children - role of adipocytokines". Pediatr Res., 2007, 61, 640.
16. Soliman P.T., Wu D., Tortolero-Luna G., Schmeler KM.: "Association between adiponectin, insulin resistance, and endometrial cancer". Cancer, 2006, 106, 2376.
17. Cust A.E., Kaaks R., Friedenreich C., Bonnet F., Laville M., Lukanova A. et al.: "Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women". J. Clin. Endocrinol. Metabol., 2007, 92, 255.
18. Dal Maso L., Augustin L.S., Karalis A.: "Circulating adiponectin and endometrial cancer risk". J. Clin. Endocrinol. Metabol., 2004, 89, 1160-3.
19. Petridou B., Mantzoros C., Dessypris N.: "Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece". J. Clin. Endocrinol. Metabol., 2003, 88, 993.
20. Takemura Y., Osuga Y., Yamauchi T.: "Expression of adiponectin receptors and its possible implication in the human endometrium". Endocrinol., 2006, 147, 3203.
21. Fu Y., Luo N., Klein R.L., Garvey W.T.: "Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation". J. Lipidol. Res., 2005, 46, 1369.
22. Lihn A.S., Pedersen S.B., Richelsen B.: "Adiponectin: action, regulation and association to insulin sensitivity". Obstet. Rev., 2005, 6, 3.